These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 10208258
1. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Hesse L, Schmidt J, Kroll P. Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258 [Abstract] [Full Text] [Related]
2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF. Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J. Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989 [Abstract] [Full Text] [Related]
3. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780 [Abstract] [Full Text] [Related]
4. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy. Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M. Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121 [Abstract] [Full Text] [Related]
5. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA. Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297 [Abstract] [Full Text] [Related]
6. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC. Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021 [Abstract] [Full Text] [Related]
8. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study. de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC. Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631 [Abstract] [Full Text] [Related]
9. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD. Hay SR, Madonna RJ. Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129 [Abstract] [Full Text] [Related]
10. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Hattenbach LO, Klais C, Koch FH, Gümbel HO. Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706 [Abstract] [Full Text] [Related]
12. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Lincoff H, Kreissig I. Retina; 2001 Jan; 21(2):191. PubMed ID: 11321154 [No Abstract] [Full Text] [Related]
13. Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures. Chen SN, Ho CL, Kuo YH, Ho JD. Retina; 2001 Jan; 21(5):460-3. PubMed ID: 11642374 [Abstract] [Full Text] [Related]
14. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration. van Zeeburg EJ, van Meurs JC. Ophthalmologica; 2013 Jan; 229(1):1-14. PubMed ID: 23075629 [Abstract] [Full Text] [Related]
15. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage. Kung YH, Wu TT, Hong MC, Sheu SJ. J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578 [Abstract] [Full Text] [Related]
16. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage. Hesse L, Schroeder B, Heller G, Kroll P. Retina; 2000 Oct; 20(5):500-5. PubMed ID: 11039425 [Abstract] [Full Text] [Related]
17. Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration. Tsai SC, Lin JM, Chen HY. Kaohsiung J Med Sci; 2003 Dec; 19(12):608-16. PubMed ID: 14719558 [Abstract] [Full Text] [Related]
18. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972 [Abstract] [Full Text] [Related]
19. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration]. Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V. J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910 [Abstract] [Full Text] [Related]
20. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. Hesse L, Kroll P. Adv Ther; 1997 Feb; 14(5):275-80. PubMed ID: 10174620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]